The company plans to launch a test for gram-negative bacteria next, and will work with developers and freelancers to develop additional assay content
Based on iCubate's Amplicon-Rescued Multiplex PCR technology, the iC-GPC assay is the first of the company's portfolio's to earn CE mark.
The iC-System is based on on iCubate's amplicon-rescued multiplex PCR technology, which detects multiple pathogens simultaneously.
Researchers sequenced samples from children with eczema and found that one S. aureus strain dominates during severe disease flares, though it varies by patient.
Researchers have isolated Staphylococcus saprophyticus and Gardnerella vaginalis from an 800-year-old skeleton, New Historian reports.
Researchers from the CDC and Georgia Tech tested the efficacy of using whole-genome shotgun sequencing to diagnose food-borne pathogens in outbreaks.
Two of the firm's assays were evaluated in posters presented at a recent conference, demonstrating good performance relative to commonly used non-molecular methods.
Researchers examined virulence, resistance, and transmission patterns in genome sequence data for more than 300 invasive Staphylococcus aureus isolates from Europe.
Cepheid will create Xpert cartridge tests to detect S. aureus and P. aeuginosa, to be used in clinical trials for biologics intended to prevent pneumonia.
In PLOS this week: recombination density-based method for calibrating human mutation rates, pathogen-typing approach using solid-state nanopores, and more.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.